Non-Invasive rapid assessment of patients with liver transplants using magnetic Resonance Imaging with LiverMultiScan® (RADIcAL2)

Summary

A prospective, multi-centre, biomarker trial comparing the accuracy of LiverMultiScan® against liver biopsy in the assessment of liver transplant recipients, designed in accordance with the STARD criteria.


Disease Area

Liver Disease


Product

LiverMultiScan®


Status

Complete


Country

Multiple European


Website

Find out more here

Liver Disease
Text Link
LiverMultiScan
Text Link